Nader Pourhassan, CytoDyn CEO (Photo by Jeff Kravitz/FilmMagic for CytoDyn’s Pro)
CytoDyn faces DOJ, SEC subpoenas after promoting failed Covid-19 drug
The little, PR-happy drug company publicly called out by the FDA is now getting attention from both the SEC and the Department of Justice. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
